213 related articles for article (PubMed ID: 31172620)
1. The role of cyclin-dependent kinases in oral potentially malignant disorders and oral squamous cell carcinoma.
Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):560-565. PubMed ID: 31172620
[TBL] [Abstract][Full Text] [Related]
2. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
3. CDK4, CDK6, cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer.
Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):566-573. PubMed ID: 31172614
[TBL] [Abstract][Full Text] [Related]
4. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
[TBL] [Abstract][Full Text] [Related]
6. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
7. Nothing to sneeze at: Histamine and histamine receptors in oral carcinogenesis.
Salem A; Salo T
Oral Dis; 2021 Jul; 27(5):1090-1096. PubMed ID: 32395857
[TBL] [Abstract][Full Text] [Related]
8. Expression of CDK6 in Oral Squamous Cell Carcinomas.
Andisheh-Tadbir A; Ashraf MJ; Jeiroodi N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1013-1016. PubMed ID: 29693970
[TBL] [Abstract][Full Text] [Related]
9. Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders.
Yang H; Jin X; Dan H; Chen Q
Oral Dis; 2020 May; 26(4):719-732. PubMed ID: 31056829
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma.
Huang F; Xin C; Lei K; Bai H; Li J; Chen Q
Cell Oncol (Dordr); 2020 Oct; 43(5):763-777. PubMed ID: 32495292
[TBL] [Abstract][Full Text] [Related]
12. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
13. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
14. History and future perspectives for the use of fluorescence visualization to detect oral squamous cell carcinoma and oral potentially malignant disorders.
Tomo S; Miyahara GI; Simonato LE
Photodiagnosis Photodyn Ther; 2019 Dec; 28():308-317. PubMed ID: 31600576
[TBL] [Abstract][Full Text] [Related]
15. Circadian clock gene Per2 plays an important role in cell proliferation, apoptosis and cell cycle progression in human oral squamous cell carcinoma.
Wang Q; Ao Y; Yang K; Tang H; Chen D
Oncol Rep; 2016 Jun; 35(6):3387-94. PubMed ID: 27035749
[TBL] [Abstract][Full Text] [Related]
16. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
18. CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.
Martín-Ezquerra G; Salgado R; Toll A; Baró T; Mojal S; Yébenes M; Garcia-Muret MP; Solé F; Quitllet FA; Espinet B; Pujol RM
Histol Histopathol; 2011 Jan; 26(1):71-7. PubMed ID: 21117028
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sprouty2 in human oral squamous cell carcinogenesis.
Liao PH; Wang YY; Wang WC; Chen CH; Kao YH; Hsu JW; Chen CY; Chen PH; Yuan SS; Chen YK
Arch Oral Biol; 2018 Mar; 87():131-142. PubMed ID: 29291435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
